Solta Medical, Inc. (SLTM) CEO Steps Down as Company Revamps Sales Strategy
8/7/2013 7:52:02 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Solta Medical Inc.'s top executive is leaving — with two years' salary and a consulting deal — after a disappointing second quarter and as the acquisitive cosmetic medical devices developer adjusts its sales strategy. Stephen Fanning stepped down Tuesday as president and CEO of Solta (NASDAQ: SLTM) and left the Hayward company's board of directors. He will be replaced on an interim basis by Mark Sieczkarek, who has been on Solta's board since 2006 and chairman since June.
Help employers find you! Check out all the jobs and post your resume.